Deciphera Pharmaceuticals, Inc. Form SC14D9C: Written communication by the subject company on a tender offer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2024-04-30: Form SC14D9C; Description SC14D9C; Document d785493dsc14d9c.htm.
- 2024-04-29: Form SC14D9C; Description SC14D9C; Document d813186dsc14d9c.htm.
- 2024-04-29: Form SC14D9C; Description SC14D9C; Document d836097dsc14d9c.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2024-04-30 | SC14D9C | SC14D9C | d785493dsc14d9c.htm | |
| 2024-04-29 | SC14D9C | SC14D9C | d813186dsc14d9c.htm | |
| 2024-04-29 | SC14D9C | SC14D9C | d836097dsc14d9c.htm |